in this issue
EnviroTech :: Biotech
Metabolix Signs PHA Supply Deal
July 26, 2012 | Rebecca Coons
Metabolix (Cambridge, MA) says it signed a letter of intent with Antibioticos S.A. for the toll production of biobased polyhydroxyalkanoate (PHA) at Antiobioticos’ Leon, Spain facility, a deal it calls a "significant step" toward establishing a new supply chain for its PHA-based Mirel biopolymers. The agreement comes six months after Archer Daniels Midland dissolved its PHA production joint venture with Metabolix and took ownership of the $300-million fermentation facility it built on the jv’s behalf—leaving Metabolix with no PHA...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee